The liver in HIV in Africa

Simple item page
dc.contributor.authorFeld, Jordan J
dc.contributor.authorOcama, Ponsiano
dc.contributor.authorRonald, Allan
dc.date.accessioned2021-12-15T20:57:43Z
dc.date.available2021-12-15T20:57:43Z
dc.date.issued2005
dc.description.abstractAs access to antiretroviral therapy improves across the African continent, liver disease is emerging as an important cause of morbidity and mortality among HIV-infected individuals. Although coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV), along with highly active antiretroviral therapy (HAART)induced hepatotoxicity appear to be the major causes of liver disease in this population, other diseases endemic to Africa with hepatic manifestations are influenced by HIV infection as well. In this review we present the available data on liver disease in HIV-infected populations in Africa and discuss relevant data from the rest of the world. In addition, we highlight important areas for further studyen_US
dc.identifier.citationFeld, J. J., Ocama, P., & Ronald, A. (2005). The liver in HIV in Africa. International Medical Press: Antiviral Therapy 10, 953–965en_US
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/672
dc.language.isoenen_US
dc.publisherInternational Medical Pressen_US
dc.subjectHIVen_US
dc.subjectLiveren_US
dc.subjectAfricaen_US
dc.titleThe liver in HIV in Africaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
The liver in HIV in Africa.pdf
Size:
619.86 KB
Format:
Adobe Portable Document Format
Description:
Research Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences